Maple Rock Capital Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124M Buy
1,197,996
+149,896
+14% +$13.4M 2.43% 13
2026
Q1
$75.3M Buy
1,048,100
+231,700
+28% +$17.8M 2.45% 11
2025
Q4
$64.8M Buy
+816,400
New +$64.4M 2.14% 17

Other funds holding CVS

Maple Rock Capital Partners's CVS Position: Q2 2026 in Review

Maple Rock Capital Partners increased its CVS Health (CVS) stake by 14% in Q2 2026, buying an estimated $13.4M and bringing the position to 1,197,996 shares worth $124M. The position accounts for 2.43% of the portfolio, ranked #13.

Maple Rock Capital Partners first reported a position in CVS in Q4 2025 and has held it in 3 quarters since. 2,064 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Maple Rock Capital Partners held 1,197,996 shares of CVS Health worth $124M as of Q2 2026.
  • Maple Rock Capital Partners bought 149,896 CVS Health shares in Q2 2026, an estimated $13.4M.
  • CVS Health made up 2.43% of Maple Rock Capital Partners's portfolio in Q2 2026, its #13 holding.
  • Maple Rock Capital Partners first reported a position in CVS Health in Q4 2025 and has held it in 3 quarters since.
  • 2,064 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Maple Rock Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.